Wyniki wyszukiwania:

Japan's innovators and entrepreneurs have survived recession in the 1990s to prosper in today's competitive business environment. This volume explores the struggles of entrepreneurs and civic-minded local leaders in fostering innovative activity, and identifies key business lessons for an economy in need of dynamic change. Ibata-Arens offers in-depth analysis of strategy in firms, communities and in local government. The book examines detailed case studies of high-technology manufacturers in Kyoto, Osaka and Tokyo, as well as bio-tech clusters in America--demonstrating far-reaching innovation...

Japan's innovators and entrepreneurs have survived recession in the 1990s to prosper in today's competitive business environment. This volume explores the struggles of entrepreneurs and civic-minded local leaders in fostering innovative activity, and identifies key business lessons for an economy in need of dynamic change. Ibata-Arens offers in-depth analysis of strategy in firms, communities and in local government. The book examines detailed case studies of high-technology manufacturers in Kyoto, Osaka and Tokyo, as well as bio-tech clusters in America--demonstrating far-reaching innovation...

Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further... How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private-public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of...

Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further ... How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private-public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of increasingly...